Identification of one novel pathogenic ITGB3 mutation and two known mutations in two Chinese pedigrees with hereditary Glanzmann thrombasthenia

References

• Glanzmann E. Hereditare hamorrhagische thrombasthenia: ein beitrag zur pathologie der blut plattchen. J. Kinderkr 1918;88: 1–13.
   Google Scholar
• Haghighi A, Borhany M, Ghazi A, Edwards, N, Tabaksert, A, Haghighi, A, Fatima, N, Shamsi, T.S. and Sayer, J.A. Glanzmann thrombasthenia in Pakistan: molecular analysis and identification of novel mutations. Clin Genet 2016;89(2): 187–192. doi:10.1111/cge.12622
   PubMed Web of Science ®Google Scholar
• Vijapurkar M, Ghosh K, Shetty S, McLane MA, da Silva, AMM. and Butera D.A simple, novel and robust test to diagnose type I Glanzmann thrombasthenia. Haematologica 2008;93(5): 797–798. doi:10.3324/haematol.12288
   PubMed Web of Science ®Google Scholar
• Schlegel N, Gayet O, Morel-Kopp MC, Wyler, B. The molecular genetic basis of Glanzmann’s thrombasthenia in a Gypsy population in France: identification of a new mutation on the alpha IIb gene. Blood 1995;86(3): 977–982.
   PubMed Web of Science ®Google Scholar
• Rosenberg N, Hauschner H, Mor-Cohen R, Landau, B. A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia. J Thromb Haemost 2005;3(12): 2764–2772. doi:10.1111/j.1538-7836.2005.01618.x
   PubMed Web of Science ®Google Scholar
• Calvete JJ. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemost 1994;72(1): 1–15.
   PubMed Web of Science ®Google Scholar
• Xiang Q, Ji SD, Zhang Z, Zhao, X, Cui, Y. M. Identification of ITGA2B and ITGB3 Single-Nucleotide Polymorphisms and Their Influences on the Platelet Function. Biomed Res Int 2016;2016: 5675084. doi:10.1155/2016/5675084
   PubMedGoogle Scholar
• Albanyan A, Al-Musa A, Alnounou R, Al Zahrani, R. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry. Int J Lab Hematol 2015;37(4): 503–508. doi:10.1111/ijlh.12320
   PubMed Web of Science ®Google Scholar
• Bellucci S, Caen J. Molecular basis of glanzmann's thrombasthenia and current strategies in treatment. Blood Reviews 2002; 16(3): 193–202. doi:10.1016/S0268-960X(02)00030-9
   PubMed Web of Science ®Google Scholar
• Tokgoz H, Ozkan DT, Caliskan U, Akar N. Novel mutations of integrin alphaIIb and beta3 genes in Turkish children with Glanzmann’s thrombasthenia. Platelets 2015;26(8): 779–782. doi:10.3109/09537104.2014.998994
   PubMed Web of Science ®Google Scholar
• Heidenreich R, Eisman R, Surrey S, Delgrosso, K. Organization of the gene for platelet glycoprotein IIb. Biochemistry 1990;29(5): 1232–1244. doi:10.1021/bi00457a020
   PubMed Web of Science ®Google Scholar
• Wilhide CC, JIn Y, Guo Q, Li L, Li SX, Rubin E, Bray PF. The human integrin beta3 gene is 63kb and contains a 5ʹ-UTR sequence regulating expression. Blood 1997;90(10): 3951–3961.
   PubMed Web of Science ®Google Scholar
• Nair S, Ghosh K, Shetty S, Mohanty D. Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients. J Thromb Haemost 2005;3(3): 482–488. doi:10.1111/j.1538-7836.2005.01159.x
   PubMed Web of Science ®Google Scholar
• Zhou L, Jiang M, Shen H, You T. Clinical and molecular insights into Glanzmann’s thrombasthenia in China. Clin Genet 2018;94(2): 213–220. doi:10.1111/cge.13366
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick, D. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17(5): 405–424. doi:10.1038/gim.2015.30
   PubMed Web of Science ®Google Scholar
• Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, Mumford AD, Stanworth SJ, Tinegate H. Guidelines for the use of platelet transfusions. Br J Haematol 2017;176: 365–394. doi:10.1111/bjh.14423
   PubMed Web of Science ®Google Scholar
• Poon MC, d’Oiron R. Alloimmunization in congenital deficiencies of platelet surface glycoproteins: focus on Glanzmann’s Thrombasthenia and Bernard-Soulier’s Syndrome. Semin Thromb Hemost 2018;44(6): 604–614. doi:10.1055/s-0038-1648233
   PubMed Web of Science ®Google Scholar
• Kazemi A, Abolghasemi H, Kazemzadeh S, Vahidi, R. Molecular characterization of Glanzmann’s thrombasthenia in Iran: identification of three novel mutations. Blood Coagul Fibrinolysis 2017;28(8): 681–686. doi:10.1097/MBC.0000000000000533
   PubMed Web of Science ®Google Scholar
• Miao LZ, Gan FY, Gong Y, Qu, J. Z, Wang, J. Y. Molecular analysis of gene mutations in eight patients with Glanzmann’s thrombasthenia. Zhonghua Yi Xue Za Zhi 2018;98(30): 2418–2423.
   PubMedGoogle Scholar
• Recht M, Chitlur M, Lam D. Epistaxis as a Common Presenting Symptom of Glanzmann’s Thrombasthenia, a Rare Qualitative Platelet Disorder: illustrative Case Examples. Case Rep Emerg Med 2017;2017: 8796425.
   PubMedGoogle Scholar
• Ambo H, Kamata T, Handa M, Taki M, Kuwajima M, Kawai Y. Three Novel Integrin b3 Subunit Missense Mutations (H280P, C560F, and G579S) in Thrombasthenia, Including One (H280P) Prevalent in Japanese Patients. Biochem Biophys Res Commun 1998;251: 763–768. doi:10.1006/bbrc.1998.9526
   PubMed Web of Science ®Google Scholar
• Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes Ro, Phillips DR, Wagner DD. CD40L stabilizes arterial thrombi by a beta3 integrin–dependent mechanism. Nat Med 2002;8(3): 247–252. doi:10.1038/nm0302-247
   PubMed Web of Science ®Google Scholar
• Ni H, Denis CV, Subbarao S, Degen, J.L, Sato, T.N, Hynes, R.O, Wagner, D.D. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000;106(3): 385–392. doi:10.1172/JCI9896
   PubMed Web of Science ®Google Scholar
• Mor-Cohen R, Rosenberg N, Peretz H, Landau, M, Coller, B.S, Awidi, A, Seligsohn, U. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian familied with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3. Thromb Haemost 2007;98(6): 1257–1265. doi:10.1160/TH07-04-0248
   PubMed Web of Science ®Google Scholar
• Wang R, Shattil SJ, Ambruso DR, Newman, P.J. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex. J Clin Invest 1997;100(9): 2393–2403. doi:10.1172/JCI119638
   PubMed Web of Science ®Google Scholar
• D’Andrea G, Margaglione M. Glanzmann’s thrombasthenia: modulation of clinical phenotype by alpha2C807T gene polymorphism. Haematologica 2003;88: 1378–1382.
   PubMed Web of Science ®Google Scholar